欧洲干眼产品市场预测至 2031 年 - 区域分析 - 按产品(人工泪液、抗炎药、泪点塞、促泌剂、口服 Omega 补充剂等)、剂型(眼药水、凝胶、胶囊和药片等)、类型(非处方药和处方药)和分销渠道(零售药店、医院药店和网上药店)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)


No. of Pages: 110    |    Report Code: TIPRE00028853    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Dry Eye Products Market
2023 年欧洲干眼症产品市场价值为 16.1759 亿美元,预计到 2031 年将达到 23.116 亿美元;预计 2023 年至 2031 年的复合年增长率为 4.6%。

老年人口激增推动欧洲干眼症产品市场

干眼症是一种常见的眼部疾病,影响相当一部分人口,尤其是 50 岁以上的人群。中老年人是这种综合症的更常见目标,可能与隐形眼镜的使用、自身免疫性疾病的流行、全身药物影响和屈光手术有关。由于预期寿命的增加以及老年人口病例的增加,干眼症的负担将继续激增。根据世界卫生组织 (WHO) 的数据,到 2030 年,60 岁及以上人口将从 2020 年的 10 亿增加到 14 亿;到 2050 年,这一数字可能还会翻一番,达到约 20 亿。预计 2020 年至 2050 年期间 80 岁及以上老年人的数量将增长两倍,达到 4.26 亿。因此,随着全球老年人口的不断增长,对人工泪液等干眼产品的需求也在增加。

欧洲干眼产品市场概览

欧洲干眼产品市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。该地区在欧洲干眼产品市场占有重要地位,预计在预测期内将录得强劲的复合年增长率。该地区的市场增长主要归因于青光眼发病率的上升(导致干眼症病例的增加)、新产品的供应、老龄化人口的激增以及对 DED 认识的提高。德国是一个拥有大量眼疾患者的国家。由于青光眼、白内障、视网膜脱落等眼科疾病的普遍发生,眼药水在德国变得越来越重要。根据 2021 年 5 月在《眼科杂志》上发表的《德国视网膜脱落的发病率:古腾堡健康研究的结果》,德国 35-74 岁年龄段的视网膜脱落疾病发病率为每年每 10 万人 42 人。与其他欧洲国家的估计相比,德国这个年龄段人群的视网膜脱落发病率很高。

根据联邦统计局 (Destatis) 的数据,2021 年,德国 67 岁及以上人口约为 1620 万,预计到 2060 年这一数字将上升到 2160 万。老年人的视力问题和其他疾病更为常见。在预测期内,老龄化人口更有可能患上眼部相关疾病,从而推动德国干眼产品市场的增长。

欧洲干眼产品市场收入及预测至 2031 年(百万美元)

欧洲干眼产品市场细分

欧洲干眼产品市场分为产品、剂型、类型、分销渠道和国家。

根据产品,欧洲干眼产品市场细分为人工泪液、抗炎药、泪点塞、促泌剂、口服欧米茄补充剂等。人工泪液部分在 2023 年占据了欧洲干眼产品市场的最大份额。此外,抗炎药部分细分为环孢菌素、皮质类固醇等。此外,泪点塞部分细分为可溶解和可拆卸。

就剂型而言,欧洲干眼产品市场细分为眼药水、凝胶、胶囊和片剂等。眼药水部分在 2023 年占据了欧洲干眼产品最大的市场份额。

按类型,欧洲干眼产品市场分为 OTC 和处方。OTC 部分在 2023 年占据了欧洲干眼产品更大的市场份额。

根据分销渠道,欧洲干眼产品市场分为零售药店、医院药店和在线药店。零售药店部分在 2023 年占据了欧洲干眼产品最大的市场份额。

根据国家/地区,欧洲干眼产品市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。 2023 年,德国占据了欧洲干眼症产品市场的主导地位。

参天制药有限公司、强生公司、OASIS Medical、URSAPHARM Arzneimittel GmbH、乐敦制药有限公司、OCuSOFT Inc、博士伦医疗公司、艾伯维公司、Prestige Consumer Healthcare Inc、Farmigea SpA 和爱尔康公司是欧洲干眼症产品市场的一些领先公司。

Europe Dry Eye Products Strategic Insights

Strategic insights for Europe Dry Eye Products involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-dry-eye-products-market-strategic-framework.webp
Get more information on this report

Europe Dry Eye Products Report Scope

Report Attribute Details
Market size in 2023 US$ 1,617.59 Million
Market Size by 2031 US$ 2,311.60 Million
Global CAGR (2023 - 2031) 4.6%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品
  • 人工泪液
  • 抗炎药
  • 泪点塞
  • 促泌剂
  • 口服欧米茄补充剂
By 剂型
  • 眼药水
  • 凝胶
  • 胶囊
  • 药片
By 类型
  • OTC,处方
By 分销渠道
  • 零售药店
  • 医院药店
  • 网上药店
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Santen Pharmaceutical Co Ltd
  • Johnson & Johnson
  • OASIS Medical
  • URSAPHARM Arzneimittel GmbH
  • Rohto Pharmaceutical Co Ltd
  • OCuSOFT Inc.
  • Bausch Health Companies Inc
  • AbbVie Inc
  • Prestige Consumer Healthcare Inc
  • Farmigea SpA
  • Get more information on this report

    Europe Dry Eye Products Regional Insights

    The regional scope of Europe Dry Eye Products refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-dry-eye-products-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Dry Eye Products Market

    1. Santen Pharmaceutical Co Ltd
    2. Johnson & Johnson
    3. OASIS Medical
    4. URSAPHARM Arzneimittel GmbH
    5. Rohto Pharmaceutical Co Ltd
    6. OCuSOFT Inc.
    7. Bausch Health Companies Inc
    8. AbbVie Inc
    9. Prestige Consumer Healthcare Inc
    10. Farmigea SpA
    11. Alcon AG
    Frequently Asked Questions
    How big is the Europe Dry Eye Products Market?

    The Europe Dry Eye Products Market is valued at US$ 1,617.59 Million in 2023, it is projected to reach US$ 2,311.60 Million by 2031.

    What is the CAGR for Europe Dry Eye Products Market by (2023 - 2031)?

    As per our report Europe Dry Eye Products Market, the market size is valued at US$ 1,617.59 Million in 2023, projecting it to reach US$ 2,311.60 Million by 2031. This translates to a CAGR of approximately 4.6% during the forecast period.

    What segments are covered in this report?

    The Europe Dry Eye Products Market report typically cover these key segments-

  • 产品 (人工泪液, 抗炎药, 泪点塞, 促泌剂, 口服欧米茄补充剂)
  • 剂型 (眼药水, 凝胶, 胶囊, 药片)
  • 类型 (OTC,处方)
  • What is the historic period, base year, and forecast period taken for Europe Dry Eye Products Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Dry Eye Products Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
  • Who are the major players in Europe Dry Eye Products Market?

    The Europe Dry Eye Products Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Santen Pharmaceutical Co Ltd
  • Johnson & Johnson
  • OASIS Medical
  • URSAPHARM Arzneimittel GmbH
  • Rohto Pharmaceutical Co Ltd
  • OCuSOFT Inc.
  • Bausch Health Companies Inc
  • AbbVie Inc
  • Prestige Consumer Healthcare Inc
  • Farmigea SpA
  • Alcon AG
  • Who should buy this report?

    The Europe Dry Eye Products Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Dry Eye Products Market value chain can benefit from the information contained in a comprehensive market report.